Aetna Wun Trombley, Ph.D., has served as President, Chief Executive Officer, and a member of Lycia’s board of directors since April 2020. She also served as an independent director of Carmot Therapeutics from 2016 until its acquisition by Roche in 2024. Prior to joining Lycia, Aetna was President and Chief Operating Officer of NGM Biopharmaceuticals, where she had broad strategic and operational responsibilities for nine years. At NGM, she was instrumental in establishing multiple strategic partnerships and a successful initial public offering in 2019. Previously, she served as Chief of Staff for the Chief Executive Officer of Novartis and was a management consultant at McKinsey & Company. She received a B.S. in Chemistry from the University of California, San Diego, and a Ph.D. in Chemistry from MIT.